[1]
J. J. Flores and E. P. Aguilera, “New Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD/MASH): Clinical Outcomes and Implementation Challenges”, Rev Hosp Ital B.Aires, vol. 46, no. 3, p. e0001314, Sep. 2026, doi: 10.51987/Rev.Hosp.Ital.B.Aires.v46i3.1314.